undefined

Add a bookmark to get started

Global Site
Africa
MoroccoEnglish
South AfricaEnglish
Asia Pacific
AustraliaEnglish
Hong Kong SAR ChinaEnglish简体中文
KoreaEnglish
New ZealandEnglish
SingaporeEnglish
ThailandEnglish
Europe
BelgiumEnglish
Czech RepublicEnglish
HungaryEnglish
IrelandEnglish
LuxembourgEnglish
NetherlandsEnglish
PolandEnglish
PortugalEnglish
RomaniaEnglish
Slovak RepublicEnglish
United KingdomEnglish
Middle East
BahrainEnglish
QatarEnglish
North America
Puerto RicoEnglish
United StatesEnglish
OtherForMigration

Danny McMann

Legal Director
About
Danny McMann’s practice focuses on private equity. He represents private equity houses and financial sponsors and their portfolio companies on complex cross-border M&A transactions, across a range of industries and geographies.

Danny advises on all commercial legal matters, including acquisitions, carve-out transactions, minority and growth capital investments, exits, secondaries, joint ventures, capital raises, transaction and equity structuring, management incentivisation, governance, due diligence and reputational, regulatory and compliance risks.
...
Danny McMann’s practice focuses on private equity. He represents private equity houses and financial sponsors and their portfolio companies on complex cross-border M&A transactions, across a range of industries and geographies.

Danny advises on all commercial legal matters, including acquisitions, carve-out transactions, minority and growth capital investments, exits, secondaries, joint ventures, capital raises, transaction and equity structuring, management incentivisation, governance, due diligence and reputational, regulatory and compliance risks.
 
Professional QualificationsAttorney-at-law admitted with the Supreme Court of New York

EXPERIENCE

Bain Capital:

  • on its acquisition of a majority stake in Maesa, a global beauty brand incubator;
  • on its acquisition of Bugaboo International, a Dutch design company that develops and produces mobility products;
  • and Cinven on their EUR 5.4b joint public takeover of the German pharmaceutical company Stada Arzneimittel AG;
  • and Carlyle on their EUR 3.4b joint public takeover offer for the German lighting company OSR...

Bain Capital:

  • on its acquisition of a majority stake in Maesa, a global beauty brand incubator;
  • on its acquisition of Bugaboo International, a Dutch design company that develops and produces mobility products;
  • and Cinven on their EUR 5.4b joint public takeover of the German pharmaceutical company Stada Arzneimittel AG;
  • and Carlyle on their EUR 3.4b joint public takeover offer for the German lighting company OSRAM Licht AG; and
  • and Advent International in structuring a management equity plan following their DKK17 billion acquisition of card-payment company Nets Holding AS.

EW Healthcare Partners:

  • on its acquisition of a majority stake in the French pharmaceutical company Laboratoires Majorelle;
  • on its EUR750m sale of EUSA Pharma;
  • and Cognate BioServices on their acquisition of Cobra Biologics, a leading international contract development and manufacturing organization; and
  • on its sale of EUSA Pharma’s critical care business to SERB Pharmaceuticals.

Starr Investment Holdings and ACA Compliance Group:

  • on the acquisition of Cordium, a leading provider of governance, risk and compliance products and services, from Ares;
  • on the sale of Cordium Malta Limited, a provider of compliance, risk, accounting and governance services for the investment management industry in Malta; and
  • on the sale of Wheelhouse Advisors (formerly Cordium Malta Limited), a compliance and accounting business, to Pelican Capital.

Summit Partners:

  • on the sale of its majority stake in Normec, a technology-enabled provider of testing, inspection and certification services, to Astorg; and
  • on its investment in Darktrace Limited, an AI company specialising in cyber security and defence systems.

Davidson Kempner European Partners on its joint venture acquisition of the Urban Pubs & Bars business.

SK Capital on its further investment in Archroma, a Swiss-headquartered provider of specialty chemicals.

Siris Capital and Mavenir Group, a software provider for CSPs, in connection with Silver Rock’s USD125m preferred financing investment in the Mavenir Group.

Mothercare Group in relation to the restructuring & administration sale of its franchise and brand business.

Starwood Capital Group:

  • on its acquisition of a 29.42% stake in London-listed RDI Real Estate Investment Trust (REIT); and
  • on its investment in CASAFARI, a leading real estate data platform.

Vitruvian Partners:

  • on its investment in CFC Underwriting, an independent managing general agent; and
  • on its acquisition of Phlexglobal, provider of electronic Trial Master File systems and services to the life sciences industry, from Bridgepoint Development Capital.

A consortium led by Drakewood Capital on their further investment in the Waybill/Virtus platform and acquisition of Small Tubes Products, a leading U.S. redrawer of niche, small diameter copper and aluminum tubes, from Quilvest.

Indigo Capital on its sale of Premier Research, a leading middle-market contract research organisation, to Metalmark Capital.

TowerBrook Capital Partners:

  • on its acquisition of Dutch frozen food producer Van Geloven from Lion Capital;
  • on its sale of a majority stake in Van Geloven to McCain Foods;
  • on its sale of a minority stake in the TowerBrook group to Wafra; and
  • on its acquisition of the Metallum group, a European leader in metals trading, recycling and logistics, from Alpha.
Education
  • Harvard Law School, J.D., 2014
  • University of British Columbia, B.A. Medal in Arts: Head of Class, 2009

Prior Experience

Danny was a partner in the London office of a top-tier U.S. law firm prior to joining DLA.

Connect

Location

London
160 Aldersgate Street
London
EC1A 4HT
United Kingdom